Based on recent studies, it is anticipated that by 2035, the number of medical imaging AI tools approved by the US FDA will increase rapidly, with venture capital support exceeding $30 billion. Over the past seven years, the availability of AI products for medical imaging has been consistently expanding, accounting for 85% of digital health venture capital. Research indicates a strong correlation between venture capital support and AI product development, with an estimated 350 new products expected to enter the market by 2035.